Lubrizol: Strengthened Position in Medical Market
The Lubrizol Corporation has expanded its focus on the medical and healthcare market, offering one of the industry’s broadest product portfolios of thermoplastic polyurethanes (TPUs) for the production of medical device and tubing products. The company made acquisitions to extend its product line and has also increased capacity and added new support personnel in sales, marketing and manufacturing.
The portfolio additions of Isoplast and Pellethane TPU products led to a major expansion of the company’s medical business. This acquisition from Dow Chemical compliments Lubrizol’s current Thermedics Polymers, which includes production of TPU resins and extruded medical tubing. Lubrizol continues to extend its reach to new markets such as wound dressings and tapes, medical bags and orthodontics, to name a few. As a result, the company has formed the new Medical and HealthCare Group to oversee and manage business activities.
Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?
Looking for a new challenge? Check out our jobs market!
Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.